{"id":97,"date":"2019-09-22T17:51:13","date_gmt":"2019-09-22T21:51:13","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/3-6-cephalosporins\/"},"modified":"2022-03-16T12:50:23","modified_gmt":"2022-03-16T16:50:23","slug":"3-6-cephalosporins","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/3-6-cephalosporins\/","title":{"raw":"3.7 Cephalosporins","rendered":"3.7 Cephalosporins"},"content":{"raw":"<span style=\"text-align: initial;font-size: 14pt\">Cephalosporins are a slightly modified chemical \"twin\" to penicillins due to their beta-lactam chemical structure. (See Figure 3.8 for a comparison of the beta-lactam ring structure, spectrum of activity, and route of administration across different classes of medications.) Because of these similarities, some clients <\/span><span style=\"text-align: initial;font-size: 14pt\">who have allergies to penicillins <\/span><span style=\"text-align: initial;font-size: 1em\">may experience cross-sensitivity to cephalosporins.<\/span>\r\n\r\n[caption id=\"\" align=\"alignnone\" width=\"1300\"]<img title=\"&quot;OSC Microbio 14 02 BetaLactam.jpg&quot; by CNX Openstax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2019\/09\/image11-1.png\" alt=\"Illustration and chart detailing Beta-lactam ring structure \" width=\"1300\" height=\"908\" \/> Figure 3.8 Comparison of beta-lactam ring structure across different classes of medications, spectrum of activity and routes of administration<sup><span style=\"text-align: initial\">[footnote]\"<\/span><a style=\"text-align: initial\" href=\"https:\/\/openstax.org\/resources\/875df04f09b347eb5af989aec39c17218e95e976\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 14 02 BetaLactam.jpg<\/a><span style=\"text-align: initial\">\" by <\/span><a style=\"text-align: initial\" href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX Openstax<\/a><span style=\"text-align: initial\"> is licensed under<\/span><a style=\"text-align: initial\" href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\"> CC BY 4.0<\/a><span style=\"text-align: initial\"> Access for free at <\/span><a style=\"text-align: initial\" href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs<\/a><span style=\"text-align: initial\">[\/footnote]<\/span><\/sup>[\/caption]<strong>Indications for Use:<\/strong> Cephalosporins are used to treat skin and skin-structure infections, bone infections, genitourinary infections, otitis media, and community-acquired respiratory tract infections.\r\n\r\n<strong>Mechanism of Action:<\/strong> Cephalosporins are typically bactericidal and are similar to penicillin in their action within the cell wall. Cephalosporins are sometimes grouped into \"generations\" by their antimicrobial properties. The 1st-generation drugs are effective mainly against gram-positive organisms. Higher generations generally have expanded spectra against aerobic gram-negative bacilli. The 5th-generation cephalosporins are active against methicillin-resistant <a class=\"rId35\" href=\"https:\/\/www.merckmanuals.com\/professional\/infectious-diseases\/gram-positive-cocci\/staphylococcal-infections\" target=\"_blank\" rel=\"noopener noreferrer\">Staphylococcus aureus<\/a> (MRSA) or other complicated infections. <sup>[footnote]Werth, B.J. (2018, August). <em>Cephalosporins.<\/em> Merck Manual Professional Version. <a href=\"https:\/\/www.merckmanuals.com\/professional\/infectious-diseases\/bacteria-and-antibacterial-drugs\/cephalosporins\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.merckmanuals.com\/professional\/infectious-diseases\/bacteria-and-antibacterial-drugs\/cephalosporins<\/a> [\/footnote]<\/sup>\r\n\r\n<strong>Nursing Considerations Across the Lifespan:<\/strong>\u00a0 Most cephalosporins are considered safe for use in pediatrics. Some dose adjustments are required based on renal dysfunction in older adults. Cephalosporins can be given during pregnancy.\r\n\r\n<strong>Specific Administration Considerations:<\/strong> Clients who are allergic to pencillins may also be allergic to cephalosporins. Clients who consume cephalosporins while drinking alcoholic beverages may experience disulfiram-like reactions including severe headache, flushing, nausea, vomiting, etc.<sup>[footnote]Ren, S., Cao, Y., Zhang, X., Jiao, S., Qian, S., &amp; Liu, P. (2014). Cephalosporin induced disulfiram-like reaction: a retrospective review of 78 cases. <em>International Surgery, 99<\/em>(2), 142\u2013146. <a href=\"https:\/\/www.internationalsurgery.org\/doi\/full\/10.9738\/INTSURG-D-13-00086.1\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.internationalsurgery.org\/doi\/full\/10.9738\/INTSURG-D-13-00086.1<\/a>[\/footnote]\u00a0<\/sup>Additionally, like penicillins, cephalosporins may interfere with coagulability and increase a client's risk of bleeding. Cephalosporin dosing may require adjustment for clients experiencing renal impairment. Blood urea nitrogen (BUN) and creatinine should be monitored carefully to identify signs of nephrotoxicity.\r\n\r\n<strong>Client Teaching &amp; Education:<\/strong> Clients who are prescribed cephalosporins should be specifically cautioned about a disulfiram reaction, which can occur when alcohol is ingested while taking the medication.\u00a0 Additionally, individuals should be instructed to monitor for rash and signs of superinfection (such as black, furry overgrowth on tongue; vaginal itching or discharge; loose or foul-smelling stool) and report to the prescribing provider.\r\n\r\nIt is also important to note that cephalosporin can enter breastmilk and may alter bowel flora of the infant. Thus, use during breastfeeding is often discouraged.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\r\n\r\nNow let's take a closer look at the cephalosporin medication card in Table 3.6.<sup>[footnote]Daily Med, <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm<\/a>, used for hyperlinked medications in this module. Retrieved June 27, 2019.[\/footnote] <\/sup>Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n\r\nTable 3.6 Cephalosporin Medication Card [footnote]UpToDate (2021). <em>Cefazolin<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a>[\/footnote]\r\n\r\n<strong>Class:\u00a0 Cephalosporins<\/strong> (prototypes:\u00a0 1st generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=19307ff0-71de-477b-965d-ea243e5ede3a&amp;audience=consumer\" target=\"_blank\" rel=\"noopener\">cephalexin<\/a> and <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=48656c70-206d-652c-204f-62692d57616e&amp;audience=consumer\" target=\"_blank\" rel=\"noopener\">cefazolin<\/a>; 2nd generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=97675251-70b8-43bc-93ea-f9ef6bb8cb68\" target=\"_blank\" rel=\"noopener\">cefprozil<\/a>; 3rd generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=4d1ad77f-2c6b-4250-82e5-ab3574444e08\" target=\"_blank\" rel=\"noopener\">ceftriaxone<\/a>; 4th generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=28f1c403-ab91-405e-bf52-ad81b1c66220\" target=\"_blank\" rel=\"noopener\">cefepime<\/a>; 5th generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=70ac1d90-eff3-4f0b-9f46-5846c571b32f\" target=\"_blank\" rel=\"noopener\">ceftolozane<\/a>).\r\n\r\n<img class=\"aligncenter wp-image-949 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-scaled.jpg\" alt=\"Cephalosporins drug card\" width=\"2560\" height=\"1170\" \/>\r\n<div class=\"textbox textbox--examples\"><header class=\"textbox__header\">\r\n<h2>Clinical Reasoning and Decision-Making Activity 3.6a<\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n<h2><strong style=\"text-align: initial;font-family: 'Times New Roman', Georgia, 'SBL Greek', serif;font-size: 14pt\">Using the above grid information, consider the following clinical scenario question:<\/strong><\/h2>\r\nMrs. Jenkins is an 89-year-old client admitted to the medical-surgical floor for treatment of a skin infection. The admitting provider prescribes Cefazolin 1 gram every 8 hours IV.\r\n\r\nMrs. Jenkins' admission laboratory tests include renal laboratory studies reflecting:\r\n\r\n<a class=\"rId42\" href=\"https:\/\/medlineplus.gov\/ency\/article\/003462.htm\" target=\"_blank\" rel=\"noopener noreferrer\">Creatinine<\/a>: 120 \u03bcmol\/L (Normal range: 50-110 \u03bcmol\/L<sup>[footnote]U.S. National Library of Medicine, Medline Plus. (2020, February 13). <em>Basic metabolic panel.<\/em>\u00a0<a href=\"https:\/\/medlineplus.gov\/ency\/article\/003462.htm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/medlineplus.gov\/ency\/article\/003462.htm<\/a>[\/footnote]<\/sup>\r\n\r\n<a class=\"rId43\" href=\"https:\/\/medlineplus.gov\/ency\/article\/003462.htm\" target=\"_blank\" rel=\"noopener noreferrer\">Blood urea nitrogen (BUN)<\/a>: 10.5 mmol\/L (Normal: 2.9-8.2 mmol\/L)\r\n\r\n<a class=\"rId44\" href=\"https:\/\/medlineplus.gov\/ency\/article\/007305.htm\">Glomerular Filtration Rate<\/a>: 55 ml\/min (Normal: 90-120 ml\/min)<sup>[footnote]U.S. National Library of Medicine, Medline Plus. (2020, February 13). <em>Glomerular filtration rate.<\/em> <a href=\"https:\/\/medlineplus.gov\/ency\/article\/007305.htm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/medlineplus.gov\/ency\/article\/007305.htm<\/a>[\/footnote]<\/sup>\r\n\r\nOn Day 3 Mrs. Jenkins has renal laboratory studies performed again. The results are:\r\n\r\nCreatinine: 150 \u03bcmol\/L\r\n\r\nBlood urea nitrogen (BUN):\u00a0 16.8 mmol\/L\r\n\r\nGlomerular Filtration Rate: 20 ml\/min\r\n\r\nAre Day 3 findings expected or not? What course of action should the nurse take?\r\n\r\nNote: Answers to the activities can be found in the \"<a href=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/chapter-3\/\">Answer Key<\/a>\" sections at the end of the book.\r\n\r\n<\/div>\r\n<\/div>\r\n&nbsp;","rendered":"<p><span style=\"text-align: initial;font-size: 14pt\">Cephalosporins are a slightly modified chemical &#8220;twin&#8221; to penicillins due to their beta-lactam chemical structure. (See Figure 3.8 for a comparison of the beta-lactam ring structure, spectrum of activity, and route of administration across different classes of medications.) Because of these similarities, some clients <\/span><span style=\"text-align: initial;font-size: 14pt\">who have allergies to penicillins <\/span><span style=\"text-align: initial;font-size: 1em\">may experience cross-sensitivity to cephalosporins.<\/span><\/p>\n<figure style=\"width: 1300px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" title=\"&quot;OSC Microbio 14 02 BetaLactam.jpg&quot; by CNX Openstax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2019\/09\/image11-1.png\" alt=\"Illustration and chart detailing Beta-lactam ring structure\" width=\"1300\" height=\"908\" \/><figcaption class=\"wp-caption-text\">Figure 3.8 Comparison of beta-lactam ring structure across different classes of medications, spectrum of activity and routes of administration<sup><span style=\"text-align: initial\">[footnote]\"<\/span><a style=\"text-align: initial\" href=\"https:\/\/openstax.org\/resources\/875df04f09b347eb5af989aec39c17218e95e976\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 14 02 BetaLactam.jpg<\/a><span style=\"text-align: initial\">\" by <\/span><a style=\"text-align: initial\" href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX Openstax<\/a><span style=\"text-align: initial\"> is licensed under<\/span><a style=\"text-align: initial\" href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\"> CC BY 4.0<\/a><span style=\"text-align: initial\"> Access for free at <\/span><a style=\"text-align: initial\" href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs<\/a><span style=\"text-align: initial\">[\/footnote]<\/span><\/sup><\/figcaption><\/figure>\n<p><strong>Indications for Use:<\/strong> Cephalosporins are used to treat skin and skin-structure infections, bone infections, genitourinary infections, otitis media, and community-acquired respiratory tract infections.<\/p>\n<p><strong>Mechanism of Action:<\/strong> Cephalosporins are typically bactericidal and are similar to penicillin in their action within the cell wall. Cephalosporins are sometimes grouped into &#8220;generations&#8221; by their antimicrobial properties. The 1st-generation drugs are effective mainly against gram-positive organisms. Higher generations generally have expanded spectra against aerobic gram-negative bacilli. The 5th-generation cephalosporins are active against methicillin-resistant <a class=\"rId35\" href=\"https:\/\/www.merckmanuals.com\/professional\/infectious-diseases\/gram-positive-cocci\/staphylococcal-infections\" target=\"_blank\" rel=\"noopener noreferrer\">Staphylococcus aureus<\/a> (MRSA) or other complicated infections. <sup><a class=\"footnote\" title=\"Werth, B.J. (2018, August). Cephalosporins. Merck Manual Professional Version. https:\/\/www.merckmanuals.com\/professional\/infectious-diseases\/bacteria-and-antibacterial-drugs\/cephalosporins\" id=\"return-footnote-97-1\" href=\"#footnote-97-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup><\/p>\n<p><strong>Nursing Considerations Across the Lifespan:<\/strong>\u00a0 Most cephalosporins are considered safe for use in pediatrics. Some dose adjustments are required based on renal dysfunction in older adults. Cephalosporins can be given during pregnancy.<\/p>\n<p><strong>Specific Administration Considerations:<\/strong> Clients who are allergic to pencillins may also be allergic to cephalosporins. Clients who consume cephalosporins while drinking alcoholic beverages may experience disulfiram-like reactions including severe headache, flushing, nausea, vomiting, etc.<sup><a class=\"footnote\" title=\"Ren, S., Cao, Y., Zhang, X., Jiao, S., Qian, S., &amp; Liu, P. (2014). Cephalosporin induced disulfiram-like reaction: a retrospective review of 78 cases. International Surgery, 99(2), 142\u2013146. https:\/\/www.internationalsurgery.org\/doi\/full\/10.9738\/INTSURG-D-13-00086.1\" id=\"return-footnote-97-2\" href=\"#footnote-97-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a>\u00a0<\/sup>Additionally, like penicillins, cephalosporins may interfere with coagulability and increase a client&#8217;s risk of bleeding. Cephalosporin dosing may require adjustment for clients experiencing renal impairment. Blood urea nitrogen (BUN) and creatinine should be monitored carefully to identify signs of nephrotoxicity.<\/p>\n<p><strong>Client Teaching &amp; Education:<\/strong> Clients who are prescribed cephalosporins should be specifically cautioned about a disulfiram reaction, which can occur when alcohol is ingested while taking the medication.\u00a0 Additionally, individuals should be instructed to monitor for rash and signs of superinfection (such as black, furry overgrowth on tongue; vaginal itching or discharge; loose or foul-smelling stool) and report to the prescribing provider.<\/p>\n<p>It is also important to note that cephalosporin can enter breastmilk and may alter bowel flora of the infant. Thus, use during breastfeeding is often discouraged.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-97-3\" href=\"#footnote-97-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/p>\n<p>Now let&#8217;s take a closer look at the cephalosporin medication card in Table 3.6.<sup><a class=\"footnote\" title=\"Daily Med, https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm, used for hyperlinked medications in this module. Retrieved June 27, 2019.\" id=\"return-footnote-97-4\" href=\"#footnote-97-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a> <\/sup>Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.<\/p>\n<p>Table 3.6 Cephalosporin Medication Card <a class=\"footnote\" title=\"UpToDate (2021). Cefazolin. https:\/\/www.uptodate.com\/contents\/search\" id=\"return-footnote-97-5\" href=\"#footnote-97-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a><\/p>\n<p><strong>Class:\u00a0 Cephalosporins<\/strong> (prototypes:\u00a0 1st generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=19307ff0-71de-477b-965d-ea243e5ede3a&amp;audience=consumer\" target=\"_blank\" rel=\"noopener\">cephalexin<\/a> and <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=48656c70-206d-652c-204f-62692d57616e&amp;audience=consumer\" target=\"_blank\" rel=\"noopener\">cefazolin<\/a>; 2nd generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=97675251-70b8-43bc-93ea-f9ef6bb8cb68\" target=\"_blank\" rel=\"noopener\">cefprozil<\/a>; 3rd generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=4d1ad77f-2c6b-4250-82e5-ab3574444e08\" target=\"_blank\" rel=\"noopener\">ceftriaxone<\/a>; 4th generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=28f1c403-ab91-405e-bf52-ad81b1c66220\" target=\"_blank\" rel=\"noopener\">cefepime<\/a>; 5th generation: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=70ac1d90-eff3-4f0b-9f46-5846c571b32f\" target=\"_blank\" rel=\"noopener\">ceftolozane<\/a>).<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-949 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-scaled.jpg\" alt=\"Cephalosporins drug card\" width=\"2560\" height=\"1170\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-scaled.jpg 2560w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-300x137.jpg 300w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-1024x468.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-768x351.jpg 768w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-1536x702.jpg 1536w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-2048x936.jpg 2048w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-65x30.jpg 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-225x103.jpg 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/cephalosporins-1-350x160.jpg 350w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<div class=\"textbox textbox--examples\">\n<header class=\"textbox__header\">\n<h2>Clinical Reasoning and Decision-Making Activity 3.6a<\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<h2><strong style=\"text-align: initial;font-family: 'Times New Roman', Georgia, 'SBL Greek', serif;font-size: 14pt\">Using the above grid information, consider the following clinical scenario question:<\/strong><\/h2>\n<p>Mrs. Jenkins is an 89-year-old client admitted to the medical-surgical floor for treatment of a skin infection. The admitting provider prescribes Cefazolin 1 gram every 8 hours IV.<\/p>\n<p>Mrs. Jenkins&#8217; admission laboratory tests include renal laboratory studies reflecting:<\/p>\n<p><a class=\"rId42\" href=\"https:\/\/medlineplus.gov\/ency\/article\/003462.htm\" target=\"_blank\" rel=\"noopener noreferrer\">Creatinine<\/a>: 120 \u03bcmol\/L (Normal range: 50-110 \u03bcmol\/L<sup><a class=\"footnote\" title=\"U.S. National Library of Medicine, Medline Plus. (2020, February 13). Basic metabolic panel.\u00a0https:\/\/medlineplus.gov\/ency\/article\/003462.htm\" id=\"return-footnote-97-6\" href=\"#footnote-97-6\" aria-label=\"Footnote 6\"><sup class=\"footnote\">[6]<\/sup><\/a><\/sup><\/p>\n<p><a class=\"rId43\" href=\"https:\/\/medlineplus.gov\/ency\/article\/003462.htm\" target=\"_blank\" rel=\"noopener noreferrer\">Blood urea nitrogen (BUN)<\/a>: 10.5 mmol\/L (Normal: 2.9-8.2 mmol\/L)<\/p>\n<p><a class=\"rId44\" href=\"https:\/\/medlineplus.gov\/ency\/article\/007305.htm\">Glomerular Filtration Rate<\/a>: 55 ml\/min (Normal: 90-120 ml\/min)<sup><a class=\"footnote\" title=\"U.S. National Library of Medicine, Medline Plus. (2020, February 13). Glomerular filtration rate. https:\/\/medlineplus.gov\/ency\/article\/007305.htm\" id=\"return-footnote-97-7\" href=\"#footnote-97-7\" aria-label=\"Footnote 7\"><sup class=\"footnote\">[7]<\/sup><\/a><\/sup><\/p>\n<p>On Day 3 Mrs. Jenkins has renal laboratory studies performed again. The results are:<\/p>\n<p>Creatinine: 150 \u03bcmol\/L<\/p>\n<p>Blood urea nitrogen (BUN):\u00a0 16.8 mmol\/L<\/p>\n<p>Glomerular Filtration Rate: 20 ml\/min<\/p>\n<p>Are Day 3 findings expected or not? What course of action should the nurse take?<\/p>\n<p>Note: Answers to the activities can be found in the &#8220;<a href=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/chapter-3\/\">Answer Key<\/a>&#8221; sections at the end of the book.<\/p>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<div class=\"media-attributions clear\" prefix:cc=\"http:\/\/creativecommons.org\/ns#\" prefix:dc=\"http:\/\/purl.org\/dc\/terms\/\"><h2>Media Attributions<\/h2><ul><li >cephalosporins       <\/li><\/ul><\/div><hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-97-1\">Werth, B.J. (2018, August). <em>Cephalosporins.<\/em> Merck Manual Professional Version. <a href=\"https:\/\/www.merckmanuals.com\/professional\/infectious-diseases\/bacteria-and-antibacterial-drugs\/cephalosporins\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.merckmanuals.com\/professional\/infectious-diseases\/bacteria-and-antibacterial-drugs\/cephalosporins<\/a>  <a href=\"#return-footnote-97-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-97-2\">Ren, S., Cao, Y., Zhang, X., Jiao, S., Qian, S., &amp; Liu, P. (2014). Cephalosporin induced disulfiram-like reaction: a retrospective review of 78 cases. <em>International Surgery, 99<\/em>(2), 142\u2013146. <a href=\"https:\/\/www.internationalsurgery.org\/doi\/full\/10.9738\/INTSURG-D-13-00086.1\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.internationalsurgery.org\/doi\/full\/10.9738\/INTSURG-D-13-00086.1<\/a> <a href=\"#return-footnote-97-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-97-3\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-97-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-97-4\">Daily Med, <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm<\/a>, used for hyperlinked medications in this module. Retrieved June 27, 2019. <a href=\"#return-footnote-97-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-97-5\">UpToDate (2021). <em>Cefazolin<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a> <a href=\"#return-footnote-97-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><li id=\"footnote-97-6\">U.S. National Library of Medicine, Medline Plus. (2020, February 13). <em>Basic metabolic panel.<\/em>\u00a0<a href=\"https:\/\/medlineplus.gov\/ency\/article\/003462.htm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/medlineplus.gov\/ency\/article\/003462.htm<\/a> <a href=\"#return-footnote-97-6\" class=\"return-footnote\" aria-label=\"Return to footnote 6\">&crarr;<\/a><\/li><li id=\"footnote-97-7\">U.S. National Library of Medicine, Medline Plus. (2020, February 13). <em>Glomerular filtration rate.<\/em> <a href=\"https:\/\/medlineplus.gov\/ency\/article\/007305.htm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/medlineplus.gov\/ency\/article\/007305.htm<\/a> <a href=\"#return-footnote-97-7\" class=\"return-footnote\" aria-label=\"Return to footnote 7\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":103,"menu_order":7,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":["open-resources-for-nursing-open-rn"],"pb_section_license":""},"chapter-type":[48],"contributor":[68],"license":[],"class_list":["post-97","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","contributor-open-resources-for-nursing-open-rn"],"part":78,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/97","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/103"}],"version-history":[{"count":10,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/97\/revisions"}],"predecessor-version":[{"id":2604,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/97\/revisions\/2604"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/78"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/97\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=97"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=97"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=97"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=97"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}